Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005014251 | SCV005641313 | uncertain significance | Polycystic kidney disease, adult type | 2024-05-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV005387335 | SCV006045327 | uncertain significance | Inborn genetic diseases | 2025-01-21 | criteria provided, single submitter | clinical testing | The c.6400G>A (p.V2134M) alteration is located in exon 15 (coding exon 15) of the PKD1 gene. This alteration results from a G to A substitution at nucleotide position 6400, causing the valine (V) at amino acid position 2134 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |